Monogram Health In-Home Multi-Specialty Care
Complete medical care at home for patients with multiple chronic conditions
Service · HybridCompany source
Company profile
About Monogram Health
Monogram Health is the leading multi-specialty provider of in-home, evidence-based care for people with multiple chronic conditions. The company takes a comprehensive and personalized approach, treating not just one disease, but the whole person—addressing all chronic conditions along with social needs such as access to food, healthy meal plans, housing, transportation, and financial assistance. Monogram Health serves over 200,000 patients annually, most of whom have three or more progressed chronic conditions including diabetes, hypertension, chronic kidney disease, heart failure, depression, and COPD. The company's integrated care model includes in-home doctor visits, 24/7 access to physicians and nurse practitioners, medication therapy management, in-home medical testing, and dedicated care teams that work collaboratively with existing providers. Monogram Health operates as a value-based care company that takes on full risk, working primarily with Medicare Advantage, Medicaid, and Marketplace health plans. The company's approach has demonstrated significant clinical impact, including 35% fewer hospital admissions, 44% fewer ER visits, and an 8.8% MLR reduction on attributed populations. With headquarters in Nashville, Tennessee and operations hub in Tempe, Arizona, Monogram Health serves patients throughout most of the continental United States, addressing both clinical needs and socioeconomic barriers to care.
Company description Monogram Health official website
Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Monogram Health?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- cardiovascular disease
- chronic kidney disease (CKD)
- COPD
- depression
- diabetes
- heart failure
- hypertension
- obesity
Who it serves
- Health Systems
- Marketplace Plans
- Medicaid Plans
- Medicare Advantage Plans
- Payers
- Provider Groups
Deployment & integration
Hybrid deployment with recorded integration context.
Geographic context
MarketsUnited States (most of continental US)
Company sourceOfficial website
Company milestones
Platform expansion
Serving 200,000+ patients annually; $550M+ total projected medical savings in 2026; 5+ years proven success in managing full MLR risk; operations hub established in Tempe, Arizona
Partnerships
Recorded partners
- Marketplace health plans
- Medicaid plans
- Medicare Advantage plans
- National payers
- Nephrology groups
- Primary care providers
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Multispecialty Provider Platform
Integrated care delivery model for payers and health systems
Platform · HybridCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Managing comorbidities in chronic kidney disease reduces utilization and costs.BMC health services research · Dec 15, 2023
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
35% fewer hospital admissions
Clinical results from value-based care model
44% fewer ER admissions
Emergency department utilization reduction
90% savings from clinical interventions
Financial impact of care management
$550M+ total projected medical savings in 2026
Projected total cost savings
8.8% MLR Reduction
Medical Loss Ratio reduction on attributed population (2026 projection)
72 Patient Net Promoter Score
Patient satisfaction measurement
+1.15 Stars Improvement
Quality rating improvement
90% controlled A1C rate
33% higher than national average for diabetes management
Controlled blood pressure rate
39% higher than national average
Chip (Patient Case Study)
Undiagnosed kidney disease management with medication review, treatment options, and dietician support
Patient engagement achieved, comprehensive care plan established including medication management and dietary support
National Payer (unnamed)
Meeting need for in-home, multi-specialty care offerings for government health plan beneficiaries with multiple chronic conditions
35% fewer hospital admissions, 44% fewer ER admissions, 8.8% MLR reduction on attributed population
Nephrology Group (Dr. Brad Canada)
Identifying and closing critical gaps in patient care, monitoring individuals who miss regular office visits
Enabled more timely education and referrals for access through feedback on missed visits
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Monogram Health
Recent articles published on Monogram Health's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Chronic Disease Management & Digital Therapeutics
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.